Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Patient Engagement Platform Used to Improve Understanding, Treatment Compliance and Quality of Care Among Patients With Gastrointestinal Malignancies

NCT04316078 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT04316078
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04316078 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Patient Engagement Platform Used to Improve Understanding, Treatment Compliance and Quality of Care Among Patients With Gastrointestinal Malignancies
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2020
Completion date
April 15, 2022
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, colon cancer, esophageal cancer, gastric cancer, pancreas cancer, rectal cancer, small bowel cancer